Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · October 26, 2022

Prevalence and Risk Factors of Hypothalamus–Pituitary–Adrenal Axis Suppression in Infants Receiving Glucocorticoid Eye Drops After Ocular Surgery

Acta Ophthalmologica

 

Additional Info

Acta Ophthalmologica
Prevalence and risk factors for hypothalamus-pituitary-adrenal axis suppression in infants receiving glucocorticoid eye drops after ocular surgery
Acta Ophthalmol 2022 Sep 27;[EPub Ahead of Print], DC Schmidt, L Kessel, D Bach-Holm, KM Main, DA Larsen, R Bangsgaard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading